Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Disease, Alcoholic”

1,892 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,892 results

Not applicableUnknownNCT06503068
What this trial is testing

Impact of NAFLD vs MAFLD Stigma on Quality of Life in Egyptian Patients

Who this might be right for
NAFLD
Tanta University 500
Not applicableStudy completedNCT04640324
What this trial is testing

Effect of PNPLA3, TM6SF2 and MBOAT7 Genetic Variants on Non-alcoholic Fatty Liver Disease Therapeutic Outcome.

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseInsulin Resistance
University of Campania Luigi Vanvitelli 92
Testing effectiveness (Phase 2)Looking for participantsNCT06477146
What this trial is testing

Milk Thistle Clinical Trial in Pediatric NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver Disease (NAFLD)
University Hospitals Cleveland Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT03118310
What this trial is testing

Treatment of NAFLD With Two Different Diets

Who this might be right for
NAFLD
Karolinska University Hospital 74
Post-approval studies (Phase 4)Study completedNCT03910361
What this trial is testing

Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases

Who this might be right for
Type2 DiabetesNon-Alcoholic Fatty Liver Disease
Dong-A ST Co., Ltd. 51
Not applicableUnknownNCT03047668
What this trial is testing

POLY-unsaturated Fatty Acids in the Preservation of Dietary Effects on Hepatosteatosis and Energy Metabolism in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesNAFLDObesity+3 more
German Institute of Human Nutrition 200
Early research (Phase 1)WithdrawnNCT04395950
What this trial is testing

Effects of ACC Inhibitor on Lipid and Lipoprotein Metabolism

Who this might be right for
NASH (Nonalcoholic Steatohepatitis)NAFLD (Nonalcoholic Fatty Liver Disease)
Columbia University
Not applicableStudy completedNCT03149627
What this trial is testing

Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults

Who this might be right for
HBVAlcoholic HepatitisLiver Fibroses
University of Alabama at Birmingham 5,003
Not applicableStudy completedNCT05216796
What this trial is testing

Healthy Liver - Healthy Brain

Who this might be right for
Metabolic SyndromeNon-Alcoholic Fatty Liver DiseaseNAFLD+1 more
University of Texas at Austin 55
Not applicableStudy completedNCT03439917
What this trial is testing

Effects of Carnitine Supplementation on Liver and Muscle

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseInsulin Resistance
University of Nottingham 30
Large-scale testing (Phase 3)Study completedNCT00573313
What this trial is testing

Effects of SAMe in Patients With Alcoholic Liver Disease

Who this might be right for
Liver Disease, Alcoholic
University of California, Davis 94
Early research (Phase 1)Study completedNCT04142424
What this trial is testing

Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese Subjects

Who this might be right for
Metabolic DisordersNon-alcoholic Steatohepatitis
AstraZeneca 73
Testing effectiveness (Phase 2)UnknownNCT05821010
What this trial is testing

Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis

Who this might be right for
Non Alcoholic SteatohepatitisNon-Alcoholic Fatty Liver DiseaseFecal Microbiota Transplantation+6 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 48
Testing effectiveness (Phase 2)Study completedNCT05500586
What this trial is testing

The Effects of Glucagon on Hepatic Metabolism

Who this might be right for
ObesityType2diabetesNAFLD
Adrian Vella 21
Not applicableUnknownNCT01472120
What this trial is testing

Adiponectin and Circulating Macrophage Phenotypes in Non-alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non-alcoholic Fatty Liver Disease
Gulhane School of Medicine 160
Testing effectiveness (Phase 2)UnknownNCT05006430
What this trial is testing

Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis

Who this might be right for
Alcoholic Hepatitis
Prasun Kumar Jalal 50
Not applicableStudy completedNCT04452409
What this trial is testing

Enhanced Liver Function in Non-alcoholic Obese Fatty Liver Patients by Low Level Laser Therapy

Who this might be right for
Fatty Liver, NonalcoholicLiver Function
Cairo University 60
Large-scale testing (Phase 3)Active Not RecruitingNCT03900429
What this trial is testing

Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Madrigal Pharmaceuticals, Inc. 1,759
Not applicableActive Not RecruitingNCT06240039
What this trial is testing

Direct Versus Indirect Effect of Amino Acids on Hepatokines

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseObesity
University of Copenhagen 30
Large-scale testing (Phase 3)Active Not RecruitingNCT04951219
What this trial is testing

Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Madrigal Pharmaceuticals, Inc. 810
Next Page